Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Differentiated Thyroid Cancer × surufatinib × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Thyroid Neoplasms 2 Thyroid Carcinoma, Anaplastic 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Head and Neck Cancers - Salivary Gland 1 Differentiated Thyroid Cancer 1 Colorectal Neoplasms 1

Interventions

Thyrotropin Alfa 3 donafenib 2 Injections 2 surufatinib 1 pembrolizumab 1 lenvatinib 1 apatinib 1 anlotinib 1 Sorafenib 1 Iodine-131 1 Everolimus 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05989425 2023-08-14

Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer

Fudan University

Phase 2 Recruiting

EndocrineHead & Neck

Differentiated Thyroid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡